John Higgins

John Higgins is a distinguished professional with extensive experience in the biopharmaceutical industry. Currently serving as a Director at Merck since February 2001, John specializes in Process Analytics for Global Vaccines and Biologics Commercialization, focusing on next-generation manufacturing, testing, and control. Prior to this role, John was a Postdoctoral Researcher at Columbia University College of Physicians and Surgeons from August 1998 to August 2000, where research centered on gene-targeted pharmacology and inherited cardiac arrhythmias. John's career began as a Chemist at Elf Atochem from 1992 to 1994, specializing in ICP-AES and metals analysis. John holds a Ph.D. in Chemistry from Princeton University and a B.A. in Chemistry from Rutgers University.